Norman Ng: Kenny Ng discusses the latest advancements in oral targeted therapies for advanced colorectal cancer
Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post on LinkedIn:
“In this insightful video, Dr. Kenny Ng, a Medical Oncologist, discusses the latest advancements in oral targeted therapies for advanced colorectal cancer. With over 5,000 new cases reported annually in Hong Kong, including 27% diagnosed at stage IV, the urgency for effective treatment options has never been greater. Dr. Ng emphasizes the importance of considering every possible treatment, as new medications bring renewed hope to patients.
He also highlights the significance of maintaining quality of life, advocating for medications with fewer side effects that are easier to administer. Join us as we explore how these innovative therapies can extend survival while supporting a better quality of life for patients.
Don’t forget to like and share this video!”
More posts featuring Norman Ng.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023